Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Eve vs NP2GO

Eve
Graded #212

Lower grade

vs+14.200000000000003
NP2GO
Graded #37

Higher grade

The verdict

NP2GO takes it — 80.2/100 to 66/100.

NP2GO grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Both molecules across 40 states, but upper-mid pricing and no verification listing.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueNP2GO +27
54
81
Dose & formulationEve +8
88
80
Clinical oversightEven
79
79
Labs & monitoringNP2GO +26
52
78
FulfillmentNP2GO +15
67
82
Contract termsNP2GO +41
41
82
Eve · left barNP2GO · right bar

The numbers

MetricEveNP2GO
WeighScore66/10080.2/100
GradeCB−
Scorecard rank#212#37
Semaglutide$195/mo (compounded)$150/mo
Tirzepatide$195/mo (compounded)$250/mo
CoverageCoverage not published40 states
Brand-name accessYesCompounded only
Oral / sublingualYesInjection only
Eve

Graded #212 · C

Strengths

  • Genuinely women's-health-focused — fills a real gap among gender-neutral GLP-1 competitors
  • Both compounded and brand-name FDA-approved options (Wegovy/Ozempic/Mounjaro) on one platform — rare
  • LegitScript Certified with a verifiable ID
  • Publishes the FDA compounded-medication disclaimer
  • Oral sublingual semaglutide offered alongside injectable

Where it loses points

  • Full states-served list not disclosed publicly
  • 503A pharmacy partner not named, and 503A vs 503B status not specified
  • Named medical director / clinical leadership not disclosed
  • Corporate legal entity not disclosed
  • Governing law / arbitration venue not stated
NP2GO

Graded #37 · B−

Strengths

  • Both molecules
  • 40-state footprint
  • Transparent listed pricing

Where it loses points

  • Not LegitScript-verified
  • Upper-mid pricing ($150/$250)
  • Not all 50 states

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard